Bellevue Group’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-22,000
Closed -$4.67M 179
2023
Q3
$4.67M Hold
22,000
0.08% 101
2023
Q2
$4.23M Sell
22,000
-700
-3% -$139K 0.06% 105
2023
Q1
$4.6M Buy
22,700
+74
+0.3% +$11.9K 0.07% 106
2022
Q4
$2.91M Sell
22,626
-20,300
-47% -$2.62M 0.04% 119
2022
Q3
$5.87M Sell
42,926
-6,450
-13% -$1.05M 0.08% 108
2022
Q2
$8.74M Sell
49,376
-1,024
-2% -$148K 0.12% 106
2022
Q1
$7.26M Buy
50,400
+4,400
+10% +$595K 0.08% 111
2021
Q4
$7.11M Sell
46,000
-7,400
-14% -$1.24M 0.07% 115
2021
Q3
$9.07M Buy
53,400
+25,900
+94% +$4.03M 0.09% 119
2021
Q2
$4.34M Sell
27,500
-7,800
-22% -$1.16M 0.04% 134
2021
Q1
$4.9M Sell
35,300
-11,300
-24% -$1.82M 0.05% 131
2020
Q4
$8.16M Hold
46,600
0.09% 121
2020
Q3
$9.12M Sell
46,600
-8,300
-15% -$1.39M 0.13% 110
2020
Q2
$9.33M Buy
54,900
+13,500
+33% +$2.01M 0.13% 111
2020
Q1
$4.78M Buy
41,400
+4,000
+11% +$443K 0.09% 114
2019
Q4
$4.27M Sell
37,400
-43,900
-54% -$4.66M 0.07% 115
2019
Q3
$6.94M Buy
81,300
+8,300
+11% +$608K 0.13% 100
2019
Q2
$5.05M Buy
73,000
+27,200
+59% +$1.9M 0.09% 107
2019
Q1
$3.35M Buy
45,800
+10,800
+31% +$768K 0.18% 89
2018
Q4
$1.98M Sell
35,000
-11,950
-25% -$750K 0.13% 98
2018
Q3
$3.62M Sell
46,950
-2,550
-5% -$188K 0.23% 84
2018
Q2
$3.29M Buy
49,500
+650
+1% +$37.2K 0.28% 71
2018
Q1
$2.56M Sell
48,850
-4,650
-9% -$253K 0.25% 70
2017
Q4
$2.86M Buy
53,500
+8,500
+19% +$497K 0.3% 68
2017
Q3
$2.45M Buy
45,000
+6,000
+15% +$307K 0.26% 76
2017
Q2
$2.02M Hold
39,000
0.24% 81
2017
Q1
$2.45M Sell
39,000
-4,000
-9% -$250K 0.33% 72
2016
Q4
$2.27M Hold
43,000
0.46% 58
2016
Q3
$2.32M Sell
43,000
-25,000
-37% -$1.19M 0.42% 68
2016
Q2
$2.75M Hold
68,000
0.52% 58
2016
Q1
$2.39M Buy
+68,000
New +$2.28M 0.43% 71

Other funds holding SGEN

Bellevue Group's SGEN Position: Q4 2023 in Review

Bellevue Group sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 22,000 shares — an estimated $4.67M sold.

Bellevue Group first reported a position in SGEN in Q1 2016 and held it in 31 quarters. The position peaked at $9.33M in Q2 2020. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Bellevue Group reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bellevue Group sold 22,000 Seagen Inc. Common Stock shares in Q4 2023, an estimated $4.67M.
  • Bellevue Group first reported a position in Seagen Inc. Common Stock in Q1 2016 and held it in 31 quarters.
  • Bellevue Group's Seagen Inc. Common Stock position peaked at $9.33M in Q2 2020.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Bellevue Group's 13F filing for Q4 2023, filed 14 Feb 2024.